• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4期结肠癌根治性切除术后异时性腹膜癌转移的预测模型

A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative Resection.

作者信息

Tsai Tzong-Yun, You Jeng-Fu, Hsu Yu-Jen, Jhuang Jing-Rong, Chern Yih-Jong, Hung Hsin-Yuan, Yeh Chien-Yuh, Hsieh Pao-Shiu, Chiang Sum-Fu, Lai Cheng-Chou, Chiang Jy-Ming, Tang Reiping, Tsai Wen-Sy

机构信息

Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan City 33305, Taiwan.

College of Medicine, Chang Gung University, Taoyuan City 33305, Taiwan.

出版信息

Cancers (Basel). 2021 Jun 4;13(11):2808. doi: 10.3390/cancers13112808.

DOI:10.3390/cancers13112808
PMID:34200032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8200190/
Abstract

(1) Background: The aim of this study was to develop a prediction model for assessing individual mPC risk in patients with pT4 colon cancer. Methods: A total of 2003 patients with pT4 colon cancer undergoing R0 resection were categorized into the training or testing set. Based on the training set, 2044 Cox prediction models were developed. Next, models with the maximal C-index and minimal prediction error were selected. The final model was then validated based on the testing set using a time-dependent area under the curve and Brier score, and a scoring system was developed. Patients were stratified into the high- or low-risk group by their risk score, with the cut-off points determined by a classification and regression tree (CART). (2) Results: The five candidate predictors were tumor location, preoperative carcinoembryonic antigen value, histologic type, T stage and nodal stage. Based on the CART, patients were categorized into the low-risk or high-risk groups. The model has high predictive accuracy (prediction error ≤5%) and good discrimination ability (area under the curve >0.7). (3) Conclusions: The prediction model quantifies individual risk and is feasible for selecting patients with pT4 colon cancer who are at high risk of developing mPC.

摘要

(1) 背景:本研究旨在开发一种预测模型,用于评估pT4期结肠癌患者发生远处转移(mPC)的个体风险。方法:将总共2003例接受R0切除的pT4期结肠癌患者分为训练集或测试集。基于训练集,开发了2044个Cox预测模型。接下来,选择具有最大C指数和最小预测误差的模型。然后使用曲线下时间依赖面积和Brier评分基于测试集对最终模型进行验证,并开发了一个评分系统。根据风险评分将患者分层为高风险组或低风险组,截断点由分类回归树(CART)确定。(2) 结果:五个候选预测因素为肿瘤位置、术前癌胚抗原值、组织学类型、T分期和淋巴结分期。基于CART,将患者分为低风险组或高风险组。该模型具有较高的预测准确性(预测误差≤5%)和良好的鉴别能力(曲线下面积>0.7)。(3) 结论:该预测模型可量化个体风险,对于选择有发生mPC高风险的pT4期结肠癌患者是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/64bdef1a896c/cancers-13-02808-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/f14289962e05/cancers-13-02808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/ff7694414502/cancers-13-02808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/64bdef1a896c/cancers-13-02808-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/f14289962e05/cancers-13-02808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/ff7694414502/cancers-13-02808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac13/8200190/64bdef1a896c/cancers-13-02808-g003.jpg

相似文献

1
A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative Resection.T4期结肠癌根治性切除术后异时性腹膜癌转移的预测模型
Cancers (Basel). 2021 Jun 4;13(11):2808. doi: 10.3390/cancers13112808.
2
Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.结直肠癌异时性腹膜癌转移风险的个体化预测
Colorectal Dis. 2014 May;16(5):359-67. doi: 10.1111/codi.12552.
3
Tumor Depth Prediction of Gastric Cancer With a T4 Score.基于T4评分的胃癌肿瘤深度预测
Cancer Diagn Progn. 2022 Nov 3;2(6):641-647. doi: 10.21873/cdp.10154. eCollection 2022 Nov-Dec.
4
External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer.预测结肠癌和直肠癌异时性腹膜癌转移个体风险模型的外部验证
Colorectal Dis. 2016 Apr;18(4):378-85. doi: 10.1111/codi.13219.
5
A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.一种用于Ⅱ期结肠癌患者根治性切除术后复发的新型预后预测模型。
Mol Clin Oncol. 2018 Dec;9(6):697-701. doi: 10.3892/mco.2018.1733. Epub 2018 Oct 4.
6
Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study.预测结直肠癌异时性腹膜转移列线图的开发与验证:一项回顾性研究
World J Gastrointest Oncol. 2023 Jan 15;15(1):112-127. doi: 10.4251/wjgo.v15.i1.112.
7
Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer.基于列线图的模型用于预测II/III期结肠癌患者三年和五年总生存率的开发及内部验证
Cancer Manag Res. 2022 Jan 14;14:225-236. doi: 10.2147/CMAR.S335665. eCollection 2022.
8
Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.结肠癌根治性切除术后的异时性腹膜转移:了解复发的风险因素和模式。
J Surg Oncol. 2021 Feb;123(2):622-629. doi: 10.1002/jso.26322. Epub 2020 Dec 1.
9
Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?预测模型工具能否识别 ACL 重建术后阿片类药物使用时间延长的高风险患者?
Clin Orthop Relat Res. 2020 Jul;478(7):0-1618. doi: 10.1097/CORR.0000000000001251.
10
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.胃癌根治性切除术后异时性多原发癌的预测。
BMC Cancer. 2013 Aug 23;13:394. doi: 10.1186/1471-2407-13-394.

引用本文的文献

1
Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal Cancers.一组T4期结直肠癌手术患者发生腹膜转移的临床和病理危险因素
Cancers (Basel). 2025 Mar 25;17(7):1103. doi: 10.3390/cancers17071103.

本文引用的文献

1
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.细胞减灭术联合腹腔热灌注化疗与单纯细胞减灭术治疗结直肠腹膜转移瘤(PRODIGE 7):一项多中心、随机、开放标签、3 期临床试验。
Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18.
2
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.二期手术加腹腔内热灌注化疗与监测在有发生结直肠腹膜转移高危患者中的对比(PROPHYLOCHIP-PRODIGE 15):一项随机、3 期研究。
Lancet Oncol. 2020 Sep;21(9):1147-1154. doi: 10.1016/S1470-2045(20)30322-3. Epub 2020 Jul 24.
3
Laparoscopic surgery for T4 colon cancer: a risk factor for peritoneal recurrences?腹腔镜手术治疗 T4 期结肠癌:腹膜复发的危险因素?
Surgery. 2020 Jul;168(1):119-124. doi: 10.1016/j.surg.2020.02.026. Epub 2020 Apr 15.
4
Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study.结直肠癌手术后异时性腹膜转移的总体风险及危险因素:一项全国性队列研究
BJS Open. 2020 Apr;4(2):284-292. doi: 10.1002/bjs5.50247. Epub 2020 Jan 9.
5
Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis.T4期结肠癌的复发模式及预后:单机构分析
J Surg Oncol. 2020 Feb;121(2):337-341. doi: 10.1002/jso.25766. Epub 2019 Nov 14.
6
Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?预防性 HIPEC 在 pT4 结直肠肿瘤中的应用:积极治疗还是过度治疗?
Ann Surg Oncol. 2020 Apr;27(4):1094-1100. doi: 10.1245/s10434-019-07970-z. Epub 2019 Oct 29.
7
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.局部晚期结肠癌患者的辅助腹腔内热化疗(COLOPEC):一项多中心、开放标签、随机试验。
Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770. doi: 10.1016/S2468-1253(19)30239-0. Epub 2019 Jul 29.
8
Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial.二期和三期腹腔镜探查用于 pT4 期结肠癌患者以早期发现腹膜转移;COLOPEC 2 随机多中心试验。
BMC Cancer. 2019 Mar 21;19(1):254. doi: 10.1186/s12885-019-5408-8.
9
Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer.局部晚期结肠癌中 pT 分期和腹膜侵犯的预后影响。
Dis Colon Rectum. 2019 Jun;62(6):684-693. doi: 10.1097/DCR.0000000000001367.
10
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?含奥沙利铂 HIPEC 治疗结直肠腹膜转移:路的尽头?
Eur J Surg Oncol. 2019 Mar;45(3):400-402. doi: 10.1016/j.ejso.2018.10.542. Epub 2018 Oct 31.